Trump's FDA pick faces Republican doubts as confirmation deadline nears
The FDA is set to finish its safety review of the abortion pill mifepristone in March, setting up one of the most politically charged decisions the agency has faced in years.
Fire or Trash?
Your verdict on this story. One tap, no account needed.Dumpster Fire links to reporting from NBC News. We don’t rewrite the facts; the original story is one click away.
Comments
Loading comments…
Comments are automatically checked for hate, threats and spam. Community rules.